The outlook and analysis of Mainz Biomed N.V (MYNZ)’s stock

Ulysses Smith

At the time of writing, Mainz Biomed N.V [MYNZ] stock is trading at $1.43, down -2.05%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MYNZ shares have gain 9.16% over the last week, with a monthly amount glided 1.42%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Mainz Biomed N.V [NASDAQ: MYNZ] stock has seen the most recent analyst activity on February 14, 2025, when Maxim Group initiated its Buy rating and assigned the stock a price target of $14. Previously, H.C. Wainwright downgraded its rating to Neutral on November 25, 2024. On November 21, 2023, downgrade downgraded it’s rating to Neutral. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $25 on June 21, 2022.

For the past year, the stock price of Mainz Biomed N.V fluctuated between $1.21 and $10.56. Mainz Biomed N.V [NASDAQ: MYNZ] shares were valued at $1.43 at the most recent close of the market.

Analyzing the MYNZ fundamentals

Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at -20.91%, Pretax Profit Margin comes in at -24.22%, and Net Profit Margin reading is -24.22%. To continue investigating profitability, this company’s Return on Assets is posted at -1.64, Equity is -22.7 and Total Capital is -2.57. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.54.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3467 points at the first support level, and at 1.2633 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5467, and for the 2nd resistance point, it is at 1.6633.

Ratios To Look Out For

It is important to note that Mainz Biomed N.V [NASDAQ:MYNZ] has a current ratio of 0.52. Also, the Quick Ratio is 0.43, while the Cash Ratio stands at 1.05.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.